Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production

• Yang Wang,

  Affiliations Department of Translational Medicine and Department of Hepatology, the First Hospital of Jilin University, Changchun, Jilin, China, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• David R McGivern,

  Affiliations Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Division of Infectious Diseases, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Liang Cheng,

  Affiliation Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Guangming Li,

  Affiliation Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Stanley M Lemon,

  Affiliations Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Division of Infectious Diseases, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Junqi Niu ,

  * E-mail: lishan_su@med.unc.edu (LS); reszka@email.unc.edu (NJRB); junqiniu@aliyun.com (JN)

  Affiliation Department of Translational Medicine and Department of Hepatology, the First Hospital of Jilin University, Changchun, Jilin, China

  ⨯
• Lishan Su ,

  * E-mail: lishan_su@med.unc.edu (LS); reszka@email.unc.edu (NJRB); junqiniu@aliyun.com (JN)

  Affiliations Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Natalia J Reszka-Blanco

  * E-mail: lishan_su@med.unc.edu (LS); reszka@email.unc.edu (NJRB); junqiniu@aliyun.com (JN)

  Affiliation Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯